According to POLPHARMA’s policy and mission, the patients’ well-being, safety and the effectiveness of drugs as well as minimization of drug-related risks is the company’s priority. Drug use safety, and thus the patients’ health, is watched over in Polpharma by the employees of the Medical Department, which includes Pharmacovigilance and Medical Information departments.

Polpharma has implemented a Pharmacovigilance System providing procedures and processes to ensure systemization and uniformity of our activities. 

• monitoring drug use safety,
• reporting adverse effects,
• evaluating drug use-related risks and benefits following marketing authorization/registration,
• developing programs and procedures for the collection and analysis of adverse events reported to the company,
• other activities connected with detection of signals and minimization of therapy-related risks.